San Diego, CA, United States of America

Xun Wang

This inventor holds 29 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents, primarily in Plant Biotechnology. Top assignees: Pioneer Hi-Bred International, Inc., Syngenta Participations Ag, Scripps Research Institute. Active years: 1998-2023.

USPTO Granted Patents = 29 

% Patents Active = 48.3

 

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 247(Granted Patents)


Location History:

  • Urbandale, IA (US) (1998)
  • Ames, IA (US) (1998)
  • Johnston, IA (US) (2000 - 2003)
  • Chapel Hill, NC (US) (2007 - 2010)
  • Research Triangle Park, NC (US) (2009 - 2013)
  • San Diego, CA (US) (2001 - 2023)

Company Filing History:


Years Active: 1998-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Algae Growth
Alimentary Canal
Transgenic Plants
Gene Expression
Cellulose Synthase
Genetic Markers
Nucleic Acids
Fumonisin Detoxification
Phytate Metabolism
PCR Cloning
Lignin Biosynthesis
Maize Genetics
29 patents (USPTO):Explore Patents

Title: Xun Wang: Pioneering Inventor from San Diego

Introduction: Xun Wang is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Xun Wang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the industry, Xun Wang has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Xun Wang has collaborated with top scientists, engineers, and entrepreneurs, fostering a culture of creativity and excellence in his projects.

Conclusion: Xun Wang's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…